Furthermore, the aforementioned study of melanoma cell lines found that rare cells express resistance genes (e.g., EGFR, AXL, or WNT5A) at high levels and that these cells are far more likely to become tolerant once a drug is applied [47]. This evidence concerns the gene WNT5A and melanoma.